ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 18 | $642 | 0.00% |
| VAN ECK ASSOCIATES CORP | 1,178 | $42 | 0.00% |
| Allworth Financial LP | 40 | $1,426 | 0.00% |
| STIFEL FINANCIAL CORP | 9,840 | $350,797 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 472 | $16,827 | 0.00% |
| IFP Advisors, Inc | 73 | $2,602 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 100 | $3,565 | 0.00% |
| COMERICA BANK | 1,067 | $38,039 | 0.00% |
| D. E. Shaw & Co., Inc. | 6,152 | $219,319 | 0.00% |
| Parallel Advisors, LLC | 269 | $9,590 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,175 | $41,889 | 0.00% |
| HUNTINGTON NATIONAL BANK | 517 | $18,431 | 0.00% |
| CENTRAL TRUST Co | 24 | $856 | 0.00% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q3 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.